TAIPEI — Cancer treatment company Rakuten Medical said Wednesday that it will collaborate with Taiwanese drugmaker Orient Europharma (OEP) to expand the reach of an immunotherapy method in Asia.
The two companies signed an exclusive licensing agreement to develop and sell drugs and devices in Singapore, Malaysia and the Philippines, as well as Taiwan.
